BridgeMD
New treatment option for Alzheimers Disease
Official title Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
ClinicalTrials.gov ID: NCT07177352
What this study is testing
- What it's testing
- The study aims to find out who might be eligible for future Alzheimer's disease trials by screening participants.
- Who it's for
- The study is looking for individuals who may have Alzheimer's disease.
- What's involved
- Participants will go through a screening process to see if they qualify for other studies related to Alzheimer's disease.
- Time commitment
- The duration and number of visits are not specified.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 90
You may be able to join if
- \- Report of objective or subjective memory concerns (by the participant and/or their informant) within the last year with or without a previous...
You likely can't join if
- Dependency in basic activities of daily living (bADLs) due to cognitive impairment
- Visual or auditory impairment that would prevent them from performing the cognitive assessments (eyeglasses and hearing aids are permitted)
- Any self-reported evidence or known diagnosis of a neurological or neurodegenerative condition that may lead to cognitive impairment other than AD
- History of severe, clinically significant central nervous system trauma
- Any serious medical condition that precludes a participant's safe participation and completion of a clinical study
The study team makes the final eligibility decision.
Where it's taking place
- Birmingham, Alabama, United States
- Phoenix, Arizona, United States
- Sun City, Arizona, United States
- Imperial, California, United States
- Inglewood, California, United States
- Irvine, California, United States
- Long Beach, California, United States
- Oakland, California, United States
- Riverside, California, United States
- Santa Ana, California, United States
- Sherman Oaks, California, United States
- New Haven, Connecticut, United States
- Atlantis, Florida, United States
- Clermont, Florida, United States
- Lady Lake, Florida, United States
- Maitland, Florida, United States
- Miami, Florida, United States
- Ocala, Florida, United States
- Orlando, Florida, United States
- Stuart, Florida, United States
+ 147 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Birmingham, Alabama, United States; Phoenix, Arizona, United States; Sun City, Arizona, United States; Imperial, California, United States; Inglewood, California, United States; Irvine, California, United States and 161 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.